To compare the in vivo hepatic safety of VIR-2218 vs ALN-HBV, human-alanine aminotransferase-1 (h-ALT1) levels were evaluated in chimeric mice with humanized livers following administration of VIR-2218 or ALN-HBV

Authors: Ed Gane, Christian Schwabe, Jorg Taubel, Anna I. Bakardjiev, Stephen A. Huang, Maja M. Janas, Mark K. Schlegel, Martin A. Maier, Xiao Ding, Lynn E. Connolly, Phil Pang, Jae B. Kim, Vasant Jadhav

See poster

Back to Resources